MoveAgain System
Paralysis
Pre-market DevelopmentActive
Key Facts
About Blackrock Neurotech
Blackrock Neurotech is a leader in the clinical brain-computer interface (BCI) space, with a platform that has been used in human studies for over 19 years. The company's core technology involves high-density microelectrode arrays that are implanted in the brain to record neural signals and translate them into commands for external devices. It has demonstrated significant clinical proof-of-concept, enabling paralyzed patients to perform tasks like typing, eating, and operating robotic arms. While currently focused on research and limited clinical use, the company is positioning its technology for broader therapeutic commercialization.
View full company profile